Part: 12         Session: 145678910111213141516171819202122         Page 680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731731a of 999

Hospital. Since then Jordan Guttermah has been working with people who have had metathesized breast cancer that have recurred. Both giving it to patients without any other drug, but also giving it to people on 5FU, adriamycin and cytoxin, to see if it would replace BCG and Levanisol, as they have done trials with FAC and Levanisol and BCG. So they know exactly what the results in survival are with FAC plus BCG or Levanisol.

Now, interferon needs to be given immediately after operation, not at the end of -- you know, not at the time of recurrence when the body has already got a heavy load of tumor. But they have gotten responses just the same in metastic breast cancer.

And one remarkable response was in a woman who had bone pain and who also had chronic leukemia. The chronic leukemia disappeared in five days. However, she is not cured of the lung cancer, and there's a question as to whether she should be put on larger doses or be treated in some other yet to be determined way.

And by next year at this time, I'll be able to give you a big story on the subject of what happened with the use of this money.

One thing that happened was that when the American Cancer Society heard that I had spent the money to buy a substantial amount of interferon, they were absolutely shocked and said that I shouldn't have to do that, that there were large funds that could buy this material, and that they would try to do something about it. The Cancer Society has just